Target Details
| UniProt AC | P12931 |
|---|---|
| Gene Symbol | SRC |
| Protein Name | Proto-oncogene tyrosine-protein kinase Src |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF07714 (PK_Tyr_Ser-Thr) PF00017 (SH2) PF00018 (SH3_1) |
Summary
- Multi-target molecules 1,978
- Clinical molecules 816
- Avg pChEMBL 7.32
KEGG Pathways (45)
- Adherens junction
- Axon guidance
- Bacterial invasion of epithelial cells
- Bladder cancer
- C-type lectin receptor signaling pathway
- Chemical carcinogenesis - reactive oxygen species
- Chemical carcinogenesis - receptor activation
- Chemokine signaling pathway
- EGFR tyrosine kinase inhibitor resistance
- Endocrine resistance
- Endocytosis
- Epithelial cell signaling in Helicobacter pylori infection
- ErbB signaling pathway
- Estrogen signaling pathway
- Fluid shear stress and atherosclerosis
- Focal adhesion
- GABAergic synapse
- Gap junction
- GnRH signaling pathway
- Hepatitis B
- Herpes simplex virus 1 infection
- Hormone signaling
- Human cytomegalovirus infection
- IgSF CAM signaling
- Inflammatory mediator regulation of TRP channels
- Integrin signaling
- Kaposi sarcoma-associated herpesvirus infection
- Lipid and atherosclerosis
- Mitophagy - animal
- Neutrophil extracellular trap formation
- Oxytocin signaling pathway
- Pathogenic Escherichia coli infection
- Platelet activation
- Prolactin signaling pathway
- Proteoglycans in cancer
- Rap1 signaling pathway
- Regulation of actin cytoskeleton
- Relaxin signaling pathway
- Shigellosis
- Thyroid hormone signaling pathway
- Tight junction
- Tuberculosis
- VEGF signaling pathway
- Viral carcinogenesis
- Yersinia infection
Associated Diseases (2)
Active Molecules (1,978)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
VAARYSWULJUGST
|
8.4 | IC50 | 119 | Yes | |
BTIKYUUNPGWLNG
|
8.4 | IC50 | 12 | Yes | |
PHGFCPRSBHSCCN
|
8.4 | IC50 | 6 | — | |
HRNNGONZVJUBCF
|
8.3 | IC50 | 2 | — | |
WBVYPYCBLRJADB
|
8.3 | IC50 | 2 | — | |
VNNQQRZBGCTADT
|
8.3 | IC50 | 2 | Yes | |
KDTFQAJYJIGSFS
|
8.3 | IC50 | 2 | — | |
QOVBTXBRBQUBBP
|
8.3 | IC50 | 3 | — | |
ZJDFSKSBQBPOSK
|
8.3 | IC50 | 24 | Yes | |
AALWZYBTBKNLKF
|
8.3 | IC50 | 4 | — | |
AVUUHIYJPTWYNX
|
8.3 | IC50 | 9 | — | |
CVDJCAGQJXAZJI
|
8.3 | IC50 | 2 | — | |
DDCRNOXQNBDLGB
|
8.3 | IC50 | 4 | Yes | |
DTBVFMOSIXAFFR
|
8.3 | IC50 | 2 | — | |
FGBHWWCXGQAKAZ
|
8.3 | IC50 | 4 | — | |
GISQWMVPDCAGDF
|
8.3 | IC50 | 3 | — | |
GNIYUURCQFKRCB
|
8.3 | IC50 | 11 | Yes | |
HKSZLNNOFSGOKW
|
8.3 | IC50 | 408 | — | |
HTMINSIGYJFGEU
|
8.3 | IC50 | 3 | — | |
ICUDJSJDWWDBHD
|
8.3 | IC50 | 4 | — | |
ILBBINCSBKHIRY
|
8.3 | IC50 | 3 | — | |
IWGLXKVBQSBQMC
|
8.3 | IC50 | 13 | Yes | |
JNMZHJBQPQFBDM
|
8.3 | IC50 | 3 | — | |
KJNNTUJLAMNBPE
|
8.3 | IC50 | 2 | — | |
KRAOZXBAPOLPAO
|
8.3 | IC50 | 4 | — | |
NNMZLFIDOZESFR
|
8.3 | IC50 | 2 | — | |
OPENPZCNOHPQNG
|
8.3 | IC50 | 4 | — | |
RCZHVXSTTOXWRM
|
8.3 | IC50 | 3 | — | |
SALBBGQOFCZHKF
|
8.3 | IC50 | 3 | — | |
TYBHAECIGHGJDF
|
8.3 | IC50 | 2 | — | |
UPXVJAHQYQWZKZ
|
8.3 | IC50 | 3 | Yes | |
UTWWHRXSGYXKES
|
8.3 | IC50 | 3 | — | |
UUDAKQZBMTXFJA
|
8.3 | IC50 | 4 | — | |
WFIJSNHJXOWVOT
|
8.3 | IC50 | 2 | — | |
XAJQBNVFUKELGZ
|
8.3 | IC50 | 3 | — | |
XJBQSGXAJXTXAC
|
8.3 | IC50 | 5 | — | |
XKFTZKGMDDZMJI
|
8.3 | Ki | 56 | — | |
XTWSYOAQXZVJEI
|
8.3 | IC50 | 3 | — | |
ZFGRQAXIHZXQBZ
|
8.3 | IC50 | 4 | Yes | |
FIKPXCOQUIZNHB
|
8.3 | IC50 | 9 | — | |
UNNQUIYQJKNUQS
|
8.3 | IC50 | 2 | — | |
VAWLAPYBUJTXRS
|
8.3 | IC50 | 6 | Yes | |
PHXJVRSECIGDHY
|
8.3 | IC50 | 59 | — | |
BAQZVMZHRWELTR
|
8.3 | IC50 | 3 | — | |
MLLBPOJSIGXWLG
|
8.2 | IC50 | 3 | Yes | |
QXIOZIFTPMAING
|
8.2 | IC50 | 17 | — | |
BDVXUKAIEGCZSB
|
8.2 | Ki | 2 | — | |
CVTIVBFOLJQENW
|
8.2 | IC50 | 3 | — | |
GZXBBHIMZJVMAU
|
8.2 | IC50 | 3 | — | |
HDJDHNITHWVMFJ
|
8.2 | IC50 | 3 | — |